Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CogState Ltd

CGS
Current price
0.95 AUD -0.015 AUD (-1.55%)
Last closed 0.98 AUD
ISIN AU000000CGS8
Sector Healthcare
Industry Health Information Services
Exchange Australian Securities Exchange
Capitalization 169 813 477 AUD
Yield for 12 month -36.24 %
1Y
3Y
5Y
10Y
15Y
CGS
21.11.2021 - 28.11.2021

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Address: 367 Collins Street, Melbourne, VIC, Australia, 3000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.23 AUD

P/E ratio

19.3

Dividend Yield

Current Year

+102 759 708 AUD

Last Year

+93 246 014 AUD

Current Quarter

+54 067 404 AUD

Last Quarter

+42 913 292 AUD

Current Year

+27 855 321 AUD

Last Year

+19 050 948 AUD

Current Quarter

+31 831 330 AUD

Last Quarter

+5 580 736 AUD

Key Figures CGS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 6 728 297 AUD
Operating Margin TTM 19.73 %
PE Ratio 19.3
Return On Assets TTM 6.9 %
PEG Ratio
Return On Equity TTM 13.87 %
Wall Street Target Price 2.23 AUD
Revenue TTM 44 264 790 AUD
Book Value 0.24 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.3 %
Dividend Yield
Gross Profit TTM 21 044 830 AUD
Earnings per share 0.051 AUD
Diluted Eps TTM 0.051 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 11.6 %
Profit Margin 12.55 %

Dividend Analytics CGS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CGS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1.006:1
Payout Ratio
Last Split Date 06.08.2008
Dividend Date

Stock Valuation CGS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 19.3
Forward PE 22.1239
Enterprise Value Revenue 1.841
Price Sales TTM 3.8363
Enterprise Value EBITDA 8.083
Price Book MRQ 2.6735

Financials CGS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CGS

For 52 weeks

0.81 AUD 1.59 AUD
50 Day MA 0.97 AUD
Shares Short Prior Month
200 Day MA 1.17 AUD
Short Ratio
Shares Short
Short Percent